Assembly Bill A2795

2019-2020 Legislative Session

Relates to extending the preferred drug program to medicaid managed care providers and health plans; repealer

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

multi-Sponsors

2019-A2795 (ACTIVE) - Details

See Senate Version of this Bill:
S5923
Current Committee:
Assembly Ways And Means
Law Section:
Social Services Law
Laws Affected:
Add §365-i, rpld §364-j subs 25 & 25-a, Soc Serv L; amd §§270 & 272, add §274-a, Pub Health L
Versions Introduced in Other Legislative Sessions:
2015-2016: A9271
2017-2018: A4233

2019-A2795 (ACTIVE) - Summary

Extends the preferred drug program to medicaid managed care providers and offers the program to other health plans.

2019-A2795 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   2795
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 25, 2019
                                ___________
 
 Introduced by M. of A. GOTTFRIED, THIELE, RODRIGUEZ, MOSLEY, MAGNARELLI,
   LUPARDO,  CRESPO, BLAKE, GALEF, JAFFEE, SEAWRIGHT, MONTESANO, GUNTHER,
   LIFTON, DINOWITZ, OTIS, ABINANTI, HYNDMAN,  ORTIZ,  COLTON  --  Multi-
   Sponsored  by  --  M. of A. CARROLL, COOK, CROUCH, ENGLEBRIGHT, GLICK,
   SIMON -- read once and referred to the Committee on Health

 AN ACT to amend the social services law and the public  health  law,  in
   relation  to  extending the preferred drug program to medicaid managed
   care providers and offering the program to other health plans; and  to
   repeal certain provisions of the social services law relating thereto
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Legislative findings. This legislature finds that the costs
 of many prescription drugs in the market have been escalating  unreason-
 ably.  The  preferred  drug program and the clinical drug review program
 under the public health law provide effective  mechanisms  for  assuring
 access  to  quality,  effective and safe drugs to patients at reasonable
 cost. Providing prescription  drugs  to  Medicaid  managed  health  care
 provider  participants through these programs will maximize the Medicaid
 program's ability  to  negotiate  more  substantial  rebates  with  drug
 manufacturers  (effectively,  lower  prices),  while protecting Medicaid
 managed care provider participants. Offering non-Medicaid  health  plans
 the  opportunity  to  use these programs will help lower costs for those
 health plans and those who pay their premiums, while protecting individ-
 uals covered by those plans, and will also further increase the  negoti-
 ating power of the programs.
   §  2. The social services law is amended by adding a new section 365-i
 to read as follows:
   § 365-I. PRESCRIPTION DRUGS IN MEDICAID MANAGED  CARE  PROGRAMS.    1.
 DEFINITIONS. (A) THE DEFINITIONS OF TERMS IN SECTION TWO HUNDRED SEVENTY
 OF THE PUBLIC HEALTH LAW SHALL APPLY TO THIS SECTION.
   (B)  AS  USED  IN  THIS  SECTION,  UNLESS THE CONTEXT CLEARLY REQUIRES
 OTHERWISE:
   (I) "MANAGED CARE  PROVIDER"  MEANS  A  MANAGED  CARE  PROVIDER  UNDER
 SECTION  THREE HUNDRED SIXTY-FOUR-J OF THIS ARTICLE, A MANAGED LONG TERM
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.